Edward J Hennessy

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Placebo Controlled

Top Venues

Journal of medicinal chemistry

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Iacovos N Michaelides, Gavin W Collie, Ulf Börjesson, Christina Vasalou, Omar Alkhatib, Louise Barlind, Tony Cheung, Ian L Dale, Kevin J Embrey, Edward J Hennessy, Puneet Khurana, Cheryl M Koh, Michelle L Lamb, Jianming Liu, Thomas A Moss, Daniel J O'Neill, Christopher Phillips, Joseph Shaw, Arjan Snijder, R Ian Storer, Christopher J Stubbs, Fujin Han, Chengzhi Li, Jingchuan Qiao, Dong-Qing Sun, Jingwen Wang, Peng Wang, Wenzhen Yang
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor. Journal of medicinal chemistry (2023)
Claire M Patterson, Srividya B Balachander, Iain Grant, Petar Pop-Damkov, Brian Kelly, William McCoull, Jeremy S Parker, Michael Giannis, Kathryn J Hill, Francis D Gibbons, Edward J Hennessy, Paul D Kemmitt, Alexander R Harmer, Sonya Gales, Stuart Purbrick, Sean Redmond, Matthew Skinner, Lorraine Graham, J Paul Secrist, Alwin G Schuller, Shenghua Wen, Ammar Adam, Corinne Reimer, Justin Cidado, Martin Wild, Eric Gangl, Stephen E Fawell, Jamal Saeh, Barry R Davies, David J Owen, Marianne B Ashford
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy. Communications biology 4 (1) (2021)